Treatment of patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome: comment on the article by Matsubara et al.

Antirheumatic Agents/therapeutic use Autoimmune Diseases/drug therapy Central Nervous System Diseases/drug therapy Etanercept Fever/drug therapy,metabolism Humans Immunoglobulin G/therapeutic use Infant Inflammation/drug therapy,metabolism Interleukin 1 Receptor Antagonist Protein/therapeutic use Interleukin-1beta/metabolism Interleukin-6/metabolism Joint Diseases/drug therapy Meningitis, Aseptic/drug therapy,metabolism Papilledema/drug therapy,metabolism Receptors, Tumor Necrosis Factor/therapeutic use Syndrome

Antirheumatic Agents Immunoglobulin G Interleukin 1 Receptor Antagonist Protein Interleukin-1beta Interleukin-6 Receptors, Tumor Necrosis Factor Etanercept